Copyright Reports & Markets. All rights reserved.

Global mRNA Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global mRNA Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Preventive Vaccines
    • 1.3.3 Therapeutic Vaccine
    • 1.3.4 Therapeutic Drugs
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global mRNA Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global mRNA Drug Market Size & Forecast
    • 1.5.1 Global mRNA Drug Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global mRNA Drug Sales Quantity (2021-2032)
    • 1.5.3 Global mRNA Drug Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Moderna
    • 2.1.1 Moderna Details
    • 2.1.2 Moderna Major Business
    • 2.1.3 Moderna mRNA Drug Product and Services
    • 2.1.4 Moderna mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Moderna Recent Developments/Updates
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer mRNA Drug Product and Services
    • 2.2.4 Pfizer mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Pfizer Recent Developments/Updates
  • 2.3 Zydus Cadila
    • 2.3.1 Zydus Cadila Details
    • 2.3.2 Zydus Cadila Major Business
    • 2.3.3 Zydus Cadila mRNA Drug Product and Services
    • 2.3.4 Zydus Cadila mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Zydus Cadila Recent Developments/Updates
  • 2.4 Fosun Pharma
    • 2.4.1 Fosun Pharma Details
    • 2.4.2 Fosun Pharma Major Business
    • 2.4.3 Fosun Pharma mRNA Drug Product and Services
    • 2.4.4 Fosun Pharma mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Fosun Pharma Recent Developments/Updates
  • 2.5 CureVAC
    • 2.5.1 CureVAC Details
    • 2.5.2 CureVAC Major Business
    • 2.5.3 CureVAC mRNA Drug Product and Services
    • 2.5.4 CureVAC mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CureVAC Recent Developments/Updates
  • 2.6 Sri Lankan Microorganisms
    • 2.6.1 Sri Lankan Microorganisms Details
    • 2.6.2 Sri Lankan Microorganisms Major Business
    • 2.6.3 Sri Lankan Microorganisms mRNA Drug Product and Services
    • 2.6.4 Sri Lankan Microorganisms mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sri Lankan Microorganisms Recent Developments/Updates
  • 2.7 BioNtech
    • 2.7.1 BioNtech Details
    • 2.7.2 BioNtech Major Business
    • 2.7.3 BioNtech mRNA Drug Product and Services
    • 2.7.4 BioNtech mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BioNtech Recent Developments/Updates
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca mRNA Drug Product and Services
    • 2.8.4 AstraZeneca mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 AstraZeneca Recent Developments/Updates
  • 2.9 Janssen
    • 2.9.1 Janssen Details
    • 2.9.2 Janssen Major Business
    • 2.9.3 Janssen mRNA Drug Product and Services
    • 2.9.4 Janssen mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Janssen Recent Developments/Updates

3 Competitive Environment: mRNA Drug by Manufacturer

  • 3.1 Global mRNA Drug Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global mRNA Drug Revenue by Manufacturer (2021-2026)
  • 3.3 Global mRNA Drug Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of mRNA Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 mRNA Drug Manufacturer Market Share in 2025
    • 3.4.3 Top 6 mRNA Drug Manufacturer Market Share in 2025
  • 3.5 mRNA Drug Market: Overall Company Footprint Analysis
    • 3.5.1 mRNA Drug Market: Region Footprint
    • 3.5.2 mRNA Drug Market: Company Product Type Footprint
    • 3.5.3 mRNA Drug Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global mRNA Drug Market Size by Region
    • 4.1.1 Global mRNA Drug Sales Quantity by Region (2021-2032)
    • 4.1.2 Global mRNA Drug Consumption Value by Region (2021-2032)
    • 4.1.3 Global mRNA Drug Average Price by Region (2021-2032)
  • 4.2 North America mRNA Drug Consumption Value (2021-2032)
  • 4.3 Europe mRNA Drug Consumption Value (2021-2032)
  • 4.4 Asia-Pacific mRNA Drug Consumption Value (2021-2032)
  • 4.5 South America mRNA Drug Consumption Value (2021-2032)
  • 4.6 Middle East & Africa mRNA Drug Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global mRNA Drug Sales Quantity by Type (2021-2032)
  • 5.2 Global mRNA Drug Consumption Value by Type (2021-2032)
  • 5.3 Global mRNA Drug Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global mRNA Drug Sales Quantity by Application (2021-2032)
  • 6.2 Global mRNA Drug Consumption Value by Application (2021-2032)
  • 6.3 Global mRNA Drug Average Price by Application (2021-2032)

7 North America

  • 7.1 North America mRNA Drug Sales Quantity by Type (2021-2032)
  • 7.2 North America mRNA Drug Sales Quantity by Application (2021-2032)
  • 7.3 North America mRNA Drug Market Size by Country
    • 7.3.1 North America mRNA Drug Sales Quantity by Country (2021-2032)
    • 7.3.2 North America mRNA Drug Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe mRNA Drug Sales Quantity by Type (2021-2032)
  • 8.2 Europe mRNA Drug Sales Quantity by Application (2021-2032)
  • 8.3 Europe mRNA Drug Market Size by Country
    • 8.3.1 Europe mRNA Drug Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe mRNA Drug Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific mRNA Drug Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific mRNA Drug Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific mRNA Drug Market Size by Region
    • 9.3.1 Asia-Pacific mRNA Drug Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific mRNA Drug Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America mRNA Drug Sales Quantity by Type (2021-2032)
  • 10.2 South America mRNA Drug Sales Quantity by Application (2021-2032)
  • 10.3 South America mRNA Drug Market Size by Country
    • 10.3.1 South America mRNA Drug Sales Quantity by Country (2021-2032)
    • 10.3.2 South America mRNA Drug Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa mRNA Drug Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa mRNA Drug Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa mRNA Drug Market Size by Country
    • 11.3.1 Middle East & Africa mRNA Drug Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa mRNA Drug Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 mRNA Drug Market Drivers
  • 12.2 mRNA Drug Market Restraints
  • 12.3 mRNA Drug Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of mRNA Drug and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of mRNA Drug
  • 13.3 mRNA Drug Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 mRNA Drug Typical Distributors
  • 14.3 mRNA Drug Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global mRNA Drug market size was valued at US$ 461 million in 2025 and is forecast to a readjusted size of US$ 641 million by 2032 with a CAGR of 4.9% during review period.
    Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global mRNA Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global mRNA Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global mRNA Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global mRNA Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global mRNA Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for mRNA Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global mRNA Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Pfizer, Zydus Cadila, Fosun Pharma, CureVAC, Sri Lankan Microorganisms, BioNtech, AstraZeneca, Janssen, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    mRNA Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Preventive Vaccines
    Therapeutic Vaccine
    Therapeutic Drugs
    Market segment by Application
    Hospital
    Clinic
    Major players covered
    Moderna
    Pfizer
    Zydus Cadila
    Fosun Pharma
    CureVAC
    Sri Lankan Microorganisms
    BioNtech
    AstraZeneca
    Janssen
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe mRNA Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of mRNA Drug, with price, sales quantity, revenue, and global market share of mRNA Drug from 2021 to 2026.
    Chapter 3, the mRNA Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the mRNA Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and mRNA Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Drug.
    Chapter 14 and 15, to describe mRNA Drug sales channel, distributors, customers, research findings and conclusion.

    Buy now